B-hSNCA*A53T mice plus

C57BL/6JNifdc-Gt(ROSA)26Sortm1(Thy1-SNCA*A53T)BcgenSncatm1Bcgen/Bcgen • 114090

B-hSNCA*A53T mice plus

Product nameB-hSNCA*A53T mice plus
Catalog number114090
Strain nameC57BL/6JNifdc-Gt(ROSA)26Sortm1(Thy1-SNCA*A53T)BcgenSncatm1Bcgen/Bcgen
Strain backgroundC57BL/6JNifdc
NCBI gene ID6622 (Human)
AliasesPD1, NACP, PARK1, PARK4

在此页面上

  • Description
  • Targeting strategy
  • Phenotypic analysis

海报

查看全部

    发表文章

      Description
      • Parkinson’s disease (PD) is a complex age-related neurodegenerative disease associated with dopamine deficiency and both motor and nonmotor deficits.
      • The presence of alpha-synuclein positive cytoplasmic inclusions, termed Lewy bodies, in surviving neurons is one of the main hallmark of PD.
      • In this model, the full coding sequences of human SNCA with A53T mutation is driven by Thy1 promoter. And SNCA was specifically expressed in brain, and the A53T point mutation was confirmed via Sanger Sequencing.
      • Abnormal phosphorylated α-Syn accumulations were exclusively detectable in cortex and hippocampus from B-hSNCA*A53T mice plus.
      Targeting strategy

      Gene targeting strategy for B-hSNCA*A53T mice plus

      The full coding sequences of human SNCA with A53T mutation that is driven by mouse Thy1 promoter are inserted into mouse Gt(ROSA)26Sor locus in B-hSNCA*A53T mice plus.

      Note: The gene editing was on the B-Snca KO mouse model, so there was no endogenous mouse Snca expression in B-hSNCA*A53T mice plus.

      mRNA expression analysis

      Strain specific analysis of SNCA mRNA expression in wild-type C57BL/6JNifdc mice and B-hSNCA*A53T mice plus by RT-PCR. Brain RNA were isolated from wild-type C57BL/6JNifdc mice (+/+) and homozygous B-hSNCA*A53T mice plus (H/H), then cDNA libraries were synthesized by reverse transcription, followed by PCR with mouse or human SNCA primers. Mouse Snca mRNA was only detectable in wild-type mice. Human SNCA mRNA was exclusively detectable in homozygous B-hSNCA*A53T mice plus, but not in wild-type mice.

      Protein expression analysis

      Western blot analysis of SNCA protein expression in homozygous B-hSNCA*A53T mice plus. Various tissue lysates were collected from C57BL/6JNifdc wild-type (+/+) mice and homozygous B-hSNCA *A53T mice plus (H/H), and then analyzed by western blot with human-specific anti-SNCA antibody (abcam, ab138501). 40 μg total proteins were loaded for western blotting analysis. SNCA was only detected in hippocampus, cortex from B-hSNCA*A53T mice plus, but not from wild-type mice.

      Neuropathology analysis

      Neuropathology analysis in homozygous B-hSNCA*A53T mice plus. Pathological neuronal accumulation of phosphorylated α-Synuclein in neurons from 4-month-old homozygous male B-hSNCA*A53T mice plus. Brain from both wild-type control mice and homozygous B-hSNCA*A53T mice plus were stained with anti-alpha-synuclein (phosphor S129) antibody (abcam, ab51253). Abnormal phosphorylated α-Syn accumulations were exclusively detectable in cortex and hippocampus from B-hSNCA*A53T mice plus.